SCHEMBL11432005

SCHEMBL11432005

C1=CN2CCCNC2S1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4374658 0.61
SCHEMBL7877974 0.60
SCHEMBL17703988 0.57 MEN1 (0.30)
SCHEMBL6406378 0.57
SCHEMBL7040068 0.56
SCHEMBL4832607 0.54
SCHEMBL6549885 0.51
SCHEMBL3174810 0.51 HTR6 (0.31)
SCHEMBL8170698 0.49 HTR6 (0.30)
SCHEMBL8170693 0.49 HTR6 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4224334-A Antiinflammatory imidazothiazoles and thiazolopyrimidines DIAMOND SHAMROCK CORPORATION (US) 1980-09-23 US disclosed
US-4160768-A Anti-inflammatory 3-benzofuranyl imidazothiazole DIAMOND SHAMROCK CORPORATION (US) 1979-07-10 US disclosed
US-4110451-A ANTIINFLAMMATORY IMIDAZOTHIAZOLES AND THIAZOLOPYRIMIDINES DIAMOND SHAMROCK CORPORATION (US) 1978-08-29 US disclosed
US-4103016-A Antiinflammatory imidazothiazoles and thiazolopyrimidines DIAMOND SHAMROCK CORPORATION (US) 1978-07-25 US disclosed
US-4041167-A INHIBITING FORMATION OF GRANULOMA TISSUE DIAMOND SHAMROCK CORPORATION (US) 1977-08-09 US disclosed